Hypophosphatasia

Disease Description (Causes and Symptoms)

Neonatal cholestasis is a condition in which problems with the production, secretion, or excretion of bile lead to the accumulation of bile acids and direct (conjugated) bilirubin in hepatocytes and bile ducts. The main pathophysiology involves hepatocellular injury caused by reduced bile flow, which may progress to bile duct fibrosis and, in advanced cases, cirrhosis and portal hypertension.

Main causes

• Biliary obstruction (biliary atresia) — the most important cause of neonatal cholestasis (requires surgical treatment).
• Neonatal (idiopathic) hepatitis — congenital viruses (TORCH), bacterial infections, etc.
• Total parenteral nutrition (TPN)-associated cholestasis — common in premature infants.
• Genetic and metabolic diseases — PFIC, alpha-1 antitrypsin deficiency, bile transporter abnormalities, etc.
• Endocrine and metabolic abnormalities (such as hypothyroidism), and drug-induced causes.

Main symptoms

• Persistent jaundice (increased direct/conjugated bilirubin)
• Grayish (acholic) stools or pale stool discoloration
• Dark urine
• Hepatomegaly, (late-stage) splenomegaly
• Steatorrhea and growth failure due to malabsorption
• Pruritus (due to bile acid accumulation)
• Bleeding tendency (coagulopathy caused by vitamin K deficiency, a fat-soluble vitamin)

Urgent warning signs: Jaundice lasting more than 2 weeks after birth, gray stools, dark urine, and poor weight gain require early evaluation.

Treatment

Principle: Cause-specific treatment after determining the cause, plus supportive treatment (nutrition, vitamin supplementation, and management of itching and complications).

Cause-specific treatment

• Biliary obstruction (biliary atresia): Early surgical treatment is essential — Kasai hepatic portoenterostomy. Performing it as early as possible (generally as soon as possible within 45–60 days after birth) is favorable for the prognosis. Liver transplantation is required if the Kasai procedure fails or progressive cirrhosis develops.
• Neonatal hepatitis and infectious causes: Antiviral or antibiotic treatment targeting the causative pathogen, along with supportive care.
• TPN-associated cholestasis: Switch to oral or enteral nutrition as soon as possible, minimize and cycle TPN, and consider the use of omega-3-based lipid emulsions (e.g., fish oil components).
• Genetic and metabolic diseases: Consider specific metabolic treatment (e.g., targeted treatment for a specific enzyme deficiency) and liver transplantation.

Supportive and symptomatic treatment

• Nutritional management: Increase calorie intake above the standard (approximately 120–125% of the recommended amount); if fat malabsorption is present, consider formula containing medium-chain triglycerides (MCTs) or MCT supplementation. Monitor weight and growth.
• Vitamin and mineral supplementation: Oral supplementation of fat-soluble vitamins (A, D, E, and K) (consider intravenous fluids or injections if absorption is reduced). Supplement water-soluble vitamins and minerals (calcium, phosphorus, and zinc).
• Medications to improve bile flow: Use ursodeoxycholic acid (UDCA) to improve bile flow; the indication and dosage are determined according to the cause, age, and national guidelines.
• Treatment of pruritus: Control symptoms with cholestyramine (which adsorbs bile acids in the intestine), rifaximin/rifampin (hepatic enzyme induction), naloxone/serotonergic drugs, etc. (Pediatric specialist supervision is required.)
• Management of infection and cholangitis: Antibiotics and urgent treatment in cases of fever, abdominal pain, or worsening jaundice.
• Transfusion and coagulation management: Correct coagulation abnormalities due to insufficient vitamin K (before surgery or in cases of bleeding).

Follow-up

• Regularly check serum bilirubin (total/direct), AST/ALT, GGT, albumin, PT/INR, fat-soluble vitamin levels, and growth indices. Perform imaging, liver biopsy, and genetic testing when necessary.

Precautions (risk of complications and self-care)

• Early diagnosis and treatment are critical to the prognosis (particularly in biliary obstruction).
• Risk of visual, skeletal, and coagulation abnormalities due to fat-soluble vitamin deficiency.
• With long-term progression, cirrhosis, portal hypertension, liver failure, and the possible need for liver transplantation may occur.
• Avoid substances that burden the liver, such as medications (hepatotoxic drugs) and alcohol (maternal medications during breastfeeding).
• Close management of growth, nutrition, and vaccinations in consultation with medical professionals is necessary.

Checklist Before an Outpatient Visit (Including Items to Bring and Sample Questions)

Items to bring

• A list of currently used medications (including prescription and nonprescription drugs and supplements)
• Copies or photos of neonatal test results (birth records, newborn screening results, and previous blood tests, ultrasounds, and nuclear medicine test results)
• Photos showing stool and urine color (at multiple time points if possible)
• Weight and feeding records (feeding amount, feeding method (breast milk/formula), and weight-change graph)
• The timing and changes in symptoms (date jaundice began, changes in stool color, fever, fussiness, etc.)
• Family history (liver disease, metabolic disease, genetic disease, etc.)

Key information to provide at the outpatient visit (prepare for what the doctor may ask)

• When the jaundice began and how it has progressed, and color changes (stool and urine)
• Feeding amount and whether weight gain is occurring, and the presence or absence of vomiting or diarrhea
• Medications administered in the past and currently (especially antibiotics, antivirals, and supplements)
• Circumstances at birth (prematurity, whether TPN was used, etc.) and history of admission to the neonatal intensive care unit
• Vaccinations and current health status (fever or symptoms of infection)

Examples of General Questions to Ask the Doctor

• What do these tests (direct bilirubin, LFTs, etc.) mean? What additional tests are needed?
• What do you think is the cause? Are there any additional tests or genetic tests that need to be performed?
• What are the treatment options (medications, surgery, and liver transplantation), and what are the advantages and disadvantages of each?
• How should nutrition and vitamins be managed to support my child’s growth and development?
• How can complications after an infection or surgery (e.g., the Kasai procedure) be prevented and monitored?

Examples of Disease-Specific Questions

• My child’s stool has remained grayish (acholic). Does the current condition suggest biliary obstruction (biliary atresia)? Is immediate imaging or surgical evaluation necessary?
• If the Kasai procedure has been recommended, please explain the criteria for success (restoration of bile flow and resolution of jaundice), by how many weeks (days) after birth the procedure has the best prognosis, and how follow-up after surgery and preparation for long-term complications (cholangitis and cirrhosis) will be managed.

(Additional recommendation) Emergency signs: If gray stools, dark urine, a sudden marked decrease in feeding, weight loss, or persistent high fever occurs, seek medical attention immediately.